1. Azo dye in Zantac® causes concern

   Comment 17 January 2013 Pages: 2 - 2

2. Betel nut warning in India

   Comment 17 January 2013 Pages: 2 - 2

3. Anticholinesterase-induced behavioural changes doubtful

   Review 17 January 2013 Pages: 3 - 3

4. Risk of viral infections with clotting factor concentrates could be reduced further

   Review 17 January 2013 Pages: 3 - 3

5. Viral safety of IV immunoglobulins

   In vitro 17 January 2013 Pages: 3 - 3

6. CPMP takes action over 4 products

   Comment 17 January 2013 Pages: 4 - 4

7. Labelling misunderstanding has serious consequences.

   News item 17 January 2013 Pages: 4 - 4

8. Reducing risk of injection mix-up after birth

   Clinical study 17 January 2013 Pages: 4 - 4

9. Reducing toxicity with single isomer drugs

   Review 17 January 2013 Pages: 4 - 4

10. The association between BCG complications and HIV infection

    Review 17 January 2013 Pages: 4 - 4

11. ACE inhibitors

    Case reports 17 January 2013 Pages: 5 - 5

12. Alternative medicine

    Case report 17 January 2013 Pages: 5 - 5

13. Antacids/sucralfate

    Incidence study 17 January 2013 Pages: 5 - 5

14. Ascorbic acid

    Case report 17 January 2013 Pages: 5 - 5

15. Aspirin

    Case report 17 January 2013 Pages: 5 - 5

16. BCG

    Case report 17 January 2013 Pages: 6 - 6

17. Beclomethasone

    Case report 17 January 2013 Pages: 6 - 6

18. Beclomethasone

    Clinical study 17 January 2013 Pages: 6 - 6

19. Benzydamine

    Case report 17 January 2013 Pages: 6 - 6

20. Bezafibrate/ciprofibrate

    Incidence study 17 January 2013 Pages: 6 - 6

21. Bimolane

    Clinical study 17 January 2013 Pages: 6 - 6

22. Bleomycin

    Case report 17 January 2013 Pages: 7 - 7

23. Captopril

    Case report 17 January 2013 Pages: 7 - 7

24. Carbamazepine

    Case report 17 January 2013 Pages: 7 - 7

25. Cefalosporins

    Incidence study 17 January 2013 Pages: 7 - 7

26. Chlorodeoxyadenosine

    Case report 17 January 2013 Pages: 7 - 7

27. Cyclosporin

    Incidence study 17 January 2013 Pages: 7 - 7

28. Cyclosporin interaction

    Case reports 17 January 2013 Pages: 7 - 7

29. Cytarabine

    Case report 17 January 2013 Pages: 8 - 8

30. Dexamethasone

    Case report 17 January 2013 Pages: 8 - 8

31. Diazepam + pentobarbital withdrawal

    Case report 17 January 2013 Pages: 8 - 8

32. Diiodohydroxyquinoline

    Case report 17 January 2013 Pages: 8 - 8

33. Dipyridamole

    Case report 17 January 2013 Pages: 8 - 8

34. Doxorubicin/vincristine

    Incidence study 17 January 2013 Pages: 9 - 9

35. Epoetin

    Case report 17 January 2013 Pages: 9 - 9

36. Feprazone

    Case reports 17 January 2013 Pages: 9 - 9

37. Fludarabine

    Case report 17 January 2013 Pages: 9 - 9

38. Halothane

    Case report 17 January 2013 Pages: 10 - 10

39. Heparin

    Case report 17 January 2013 Pages: 10 - 10

40. Herbal medicines

    Case reports 17 January 2013 Pages: 10 - 10

41. Isotretinoin

    Case report 17 January 2013 Pages: 10 - 10

42. Itraconazole interaction

    Case report 17 January 2013 Pages: 10 - 10

43. Methotrexate

    Case report 17 January 2013 Pages: 11 - 11

44. Methylprednisolone

    Case report 17 January 2013 Pages: 11 - 11

45. Nifedipine

    Case reports 17 January 2013 Pages: 11 - 11

46. NSAIDs

    Incidence study 17 January 2013 Pages: 11 - 11

47. NSAIDs

    Case report 17 January 2013 Pages: 11 - 11

48. NSAIDs

    Incidence study 17 January 2013 Pages: 11 - 11

49. Paroxetine

    Case report 17 January 2013 Pages: 11 - 11

50. Phenytoin

    Case report 17 January 2013 Pages: 11 - 11